People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Seahorse Bioscience Inc | — | Biotechnology | Series A | $20.7M | $410.2M | 2012 |
| Enrich Biosystems Inc. | — | Biotechnology | Seed | $8.2M | $3.3M | 2022 |
Jay Teich at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jay Teich on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Wagner | 1 | 13 |
| David Stone | 1 | 12 |
| Fouad Azzam | 1 | 8 |
| Harry Wilcox | 1 | 6 |
| Steven Young | 1 | 6 |
| Joseph Keegan | 1 | 4 |
| Christopher McLeod | 1 | 3 |
| Qi Zhao | 1 | 2 |
| Jeffrey Hurst | 1 | 2 |
| Cynthia Green | 1 | 1 |
| James Orrell | 1 | 1 |
| Steve Chomicz | 1 | 1 |
| David Ferrick | 1 | 1 |
| Earl Lewis | 1 | 1 |
| Andrew Neilson | 1 | 1 |
| Dong Wang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.